Reporte zur Charge U3366AA

Symptomtext

allergic reaction; Initial information regarding an unsolicited valid non-serious case was received from a nurse via consumer/non-health care professional via Medical Information (Reference number- 00760331). This case involves a female patient (age unspecified) who had an allergic reaction (hypersensitivity) after receiving INFLUENZA USP TRIVAL A-B SUBVIRION VACCINE [FLUZONE]. Medical history, medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided. On an unknown date in 2009, the patient received a dose of suspect INFLUENZA USP TRIVAL A-B SUBVIRION VACCINE (lot U3366AA, expiry not reported) via unknown route in unknown administration site for prophylactic vaccination. On an unknown date the patient developed a non-serious allergic reaction (hypersensitivity) (unknown latency) following the administration of INFLUENZA USP TRIVAL A-B SUBVIRION VACCINE. It was reported, "The caller (nurse) states that a patient received FLUZONE QUADRIVALENT (from MULTI-DOSE VIAL) in 2009 Lot # U3366AA. The patient had an allergic reaction after receiving the vaccine and she would like to know if the vaccine was a swine flu (H1N1) vaccine or regular flu vaccine. The caller also would like ingredients of the 2009 Fluzone Quadrivalent Multi-dose Vials. The nurse states that the client is working with an allergist so that she can get the Coronavirus Disease (COVID vaccine) and she is the middleman." No laboratory data was reported. It was not reported if the patient received a corrective treatment for the event. At time of reporting, the outcome of the event was unknown.